Another approach used anti-CTLA-4 siRNA-loaded chitosan-lactate (CL) nanoparticles to facilitate priming anti- tumor T cells and the downregulation of CTLA-4 on tumor-infiltrating T cells were observed, which was associated with tumor regression and increased survival in a mouse tumor model. The gene discussed is CTLA4; the disease is neoplasm.